Invasive mucormycosis during treatment for acute lymphoblastic leukaemia-successful management of two life-threatening diseases

被引：4

作者：

Trobisch, Andreas ^{[1
,2
]}

Marterer, R. ^{[3
]}

Gorkiewicz, G. ^{[4
]}

Flaschberger, S. ^{[5
]}

Lackner, H. ^{[1
]}

Seidel, M. ^{[1
]}

Sperl, D. ^{[1
]}

Karastaneva, A. ^{[1
]}

Kohlmaier, B. ^{[1
]}

Egger, M. ^{[6
]}

Urban, C. ^{[1
]}

Benesch, M. ^{[1
]}

Strenger, V ^{[1
,6
,7
]}

机构：

[1] Med Univ, Dept Paediat & Adolescent Med, Div Paediat Haematol Oncol, Graz, Austria

[2] Med Univ, Dept Paediat & Adolescent Med, Div Neonatol, Graz, Austria

[3] Med Univ Graz, Dept Radiol, Div Paediat Radiol, Graz, Austria

[4] Med Univ, Diagnost & Res Inst Pathol, Graz, Austria

[5] Klinikum Klagenfurt Worthersee, Dept Paediat, Klagenfurt, Austria

[6] Med Univ, Dept Paediat & Adolescent Med, Div Paediat Pulmonol & Allergol, Graz, Austria

[7] Med Univ, Res Unit Infect Dis Immunocompromised Host, Graz, Austria

来源：

SUPPORTIVE CARE IN CANCER | 2020年 / 28卷 / 05期

关键词：

ALL; Mucormycosis; IFD; Antimycotic treatment; Chemotherapy; LIPOSOMAL AMPHOTERICIN-B; ACTINOMUCOR-ELEGANS; EUROPEAN ORGANIZATION; FUNGAL-INFECTIONS; DIAGNOSIS; GUIDELINES;

D O I：

10.1007/s00520-019-04962-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A 5-year-old patient treated for acute lymphoblastic leukaemia (ALL) developed proven pulmonary invasive fungal disease (IFD) due to Actinomucor elegans. While completing ALL treatment according to AIEOP ALL protocol 2009 for further 15 months, antifungal treatment with liposomal amphotericin B and intermittent additional posaconazole was continued until immune reconstitution 7 months after the end of ALL treatment. Repeated imaging guided treatment decisions. Twenty-six and 19 months after the end of ALL treatment and antifungal treatment, respectively, the patient is still in the first complete remission and shows no signs of active invasive fungal disease (IFD).

引用

页码：2157 / 2161

页数：5

共 47 条

[1] Invasive mucormycosis during treatment for acute lymphoblastic leukaemia—successful management of two life-threatening diseases
Andreas Trobisch
R. Marterer
G. Gorkiewicz
S. Flaschberger
H. Lackner
M. Seidel
D. Sperl
A. Karastaneva
B. Kohlmaier
M. Egger
C. Urban
M. Benesch
V. Strenger
Supportive Care in Cancer, 2020, 28 : 2157 - 2161
[2] Invasive Zygomycosis during Treatment for Acute Lymphoblastic Leukaemia - Management of Two Life Threatening Diseases
Trobisch, A.
Strenger, V.
Kohlmaier, B.
Egger, M.
Kurath-Koller, S.
Lackner, H.
Karastaneva, A.
Sorantin, E.
Urban, C.
EUROPEAN JOURNAL OF PEDIATRICS, 2017, 176 (11) : 1501 - 1501
[3] Successful Treatment of Refractory Acute Lymphoblastic Leukemia with Tisagenlecleucel in the Setting of Life-Threatening Infection
August, Keith J.
Flatt, Terrie
Hall, Erin Marie
Myers, Doug
BLOOD, 2019, 134
[4] Successful treatment of gastrointestinal mucormycosis in an adolescent with Acute Lymphoblastic Leukaemia (ALL)
Aabideen, Kanakkande
Lashkari, Harsha P.
Holmes, Keith
Taj, Mary
PEDIATRIC BLOOD & CANCER, 2012, 58 (02) : 312 - 313
[5] SUCCESSFUL TREATMENT OF INVASIVE THORACOPULMONARY MUCORMYCOSIS IN A PATIENT WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
FUKUSHIMA, T
SUMAZAKI, R
SHIBASAKI, M
SAITOH, H
FUJIGAKI, Y
KANEKO, M
AKAOGI, E
MITSUI, K
OGATA, T
TAKITA, H
CANCER, 1995, 76 (05) : 895 - 899
[6] Successful management of hepatic mucormycosis in an acute lymphoblastic leukaemia patient: a case report and review of the literature
Tuysuz, Gulen
Ozdemir, Nihal
Senyuz, Osman Faruk
Emre, Senol
Kantarcioglu, Serda
Adaletli, Ibrahim
Kepil, Nuray
Tutuncu, Cigdem
Celkan, Tiraje
MYCOSES, 2014, 57 (08) : 513 - 518
[7] Life-threatening complications associated with acute monocytic leukaemia after dental treatment
Koulocheris, P.
Metzger, M. R.
Kesting, M. R.
Hohlweg-Majert, B.
AUSTRALIAN DENTAL JOURNAL, 2009, 54 (01) : 45 - 48
[8] Successful treatment of aspergillus fungaemia in two children with acute lymphoblastic leukaemia
Atra, A
Soler, P
Calvagna, V
Meller, ST
Riley, URG
JOURNAL OF INFECTION, 1998, 36 (03) : 323 - 324
[9] Two life-threatening complications during chronic total occlusion management
Maritsa, Dimitra
Gavrielatos, Gerasimos
Dimopoulos, Antonios
Patsourakos, Nikolaos
Papakonstantinou, Nikolaos
Pisimisis, Evaggelos
POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2022, 18 (01): : 81 - 82
[10] Intestinal Mucormycosis With Rhizopus microsporus After Liver Transplantation-Successful Treatment of a Rare but Life-Threatening Complication
Vondran, Florian W. R.
Knitsch, Wolfgang
Krech, Till
Erichsen, Thomas J.
Sedlacek, Ludwig
Abbas, Mahmoud
Klempnauer, Juergen
Bektas, Hueseyin
Lehner, Frank
Kousoulas, Lampros
TRANSPLANTATION, 2014, 97 (02) : E11 - E13

← 1 2 3 4 5 →